雜志介紹

Cancer Biomarkers雜志介紹

《Cancer Biomarkers》是一本以English為主的未開放獲取國際優秀期刊，中文名稱癌癥生物標志物，本刊主要出版、報道醫學-ONCOLOGY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為2.2，最新CiteScore 指數為5.2。

本刊近期中國學者發表的論文主要有：

• ScRNA-seq revealed targeting regulator of G protein signaling 1 to mediate regulatory T cells in Hepatocellular carcinoma

  Author: Zou, Lianhong; Liu, Kaihua; Shi, Yongzhong; Li, Guowei; Li, Haiyang; Zhao, Chaoxian

• Construction and validation of a prognostic model based on ten signature cell cycle-related genes for early-stage lung squamous cell carcinoma

  Author: Zhang, Chengpeng; Huang, Yong; Fang, Chen; Liang, Yingkuan; Jiang, Dong; Li, Jiaxi; Ma, Haitao; Jiang, Wei; Feng, Yu

• Identification of therapeutic targets and prognostic biomarkers among CXC chemokines in hepatocellular carcinoma microenvironment

  Author: Yin, Zi; Ma, Tingting; Chen, Sheng; Yu, Min

• LncRNA STK4 antisense RNA 1 (STK4-AS1) promoted osteosarcoma by inhibiting p53 expression

  Author: Yao, Weitao; Hou, Jingyu; Liu, Guoqing; Wu, Fangxing; Yan, Qiang; Guo, Liangyu; Wang, Chuchu

英文介紹

Cancer Biomarkers雜志英文介紹

Concentrating on molecular biomarkers in cancer research, Cancer Biomarkers publishes original research findings (and reviews solicited by the editor) on the subject of the identification of markers associated with the disease processes whether or not they are an integral part of the pathological lesion.

The disease markers may include, but are not limited to, genomic, epigenomic, proteomics, cellular and morphologic, and genetic factors predisposing to the disease or indicating the occurrence of the disease. Manuscripts on these factors or biomarkers, either in altered forms, abnormal concentrations or with abnormal tissue distribution leading to disease causation will be accepted.